EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Peptidylprolyl Isomerase a Regulates DNA Damage Repair and Serves as a Prognostic Biomarker in Lung Adenocarcinoma

Li Zou iD, Bixin Ren, Ying Wan, Xin Wang, Ruichi Shen, Wenlang Zhu, Limin Jin, Qiliang Peng iD, Ye Tian

Dose-Response · 2026-07 · 24 (3)

DOI: 10.1177/15593258261473591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dose-Response, online erschienen am 25.07.2026. Verfasst von Li Zou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy & Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Gusu Health Talent Research Program, Suzhou Radiotherapy Clinical Medical Center, Suzhou Science and Technology Key Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study investigated the role of peptidylprolyl isomerase A (PPIA) in lung adenocarcinoma (LUAD) using bioinformatics approaches and experimental validation.

Methods

This study began by assessing PPIA expression and its prognostic significance in LUAD. We then performed functional enrichment analyses and examined CNVs, DNA methylation, DNMT activity, RNA modification, immune cell infiltration, and drug therapy efficacy. Cellular experiments were performed to confirm the role of PPIA in DNA damage repair.

Results

PPIA was overexpressed in LUAD tissues and was associated with poor prognosis, including shorter overall survival and progression-free interval. PPIA expression was correlated with CNVs, DNA methylation, DNMT activity, and RNA modification-related genes. It was also negatively associated with immune cell infiltration and immune-related gene expression, suggesting a potential immunosuppressive role. Drug sensitivity analysis indicated that PPIA may serve as a predictive biomarker for therapeutic efficacy in LUAD. In addition, PPIA expression was associated with DNA damage repair-related genes. Cellular experiments show that PPIA knockdown increases radiosensitivity and γ-H2AX foci formation, whereas PPIA overexpression exerts the opposite effects.

Conclusion

This study highlights the potential of PPIA as a prognostic biomarker and target in LUAD, particularly in the regulation of DNA damage repair and tumor immune microenvironment remodeling.

Schlagwörter

Stichwörter der Autor:innen

DNA damage repairPPIAbiomarkerlung adenocarcinomaprognosis

Autor:innen und Institutionen

  • Department of Radiotherapy & Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Institute of Radiation Medicine of Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China.
  • Kangda College of Nanjing Medical University, Nanjing, China.
  • Department of Gastrointestinal Surgery, The First People's Hospital of Taicang City, Taicang Affiliated Hospital of Soochow University, Taicang, Jiangsu, China.

ORCID-Profile: Li Zou, Qiliang Peng

Förderung

  • Gusu Health Talent Research Program
  • Suzhou Radiotherapy Clinical Medical Center
  • Suzhou Science and Technology Key Research Program
  • Suzhou Applied Basic Research (Medical and Health) Science and Technology Innovation Project
  • Scientific Research Pre-Study Fund of the Second Affiliated Hospital of Soochow University

Zitieren

APA

Zou, L., Ren, B., Wan, Y., Wang, X., Shen, R., Zhu, W., Jin, L., Peng, Q., & Tian, Y. (2026). Peptidylprolyl Isomerase a Regulates DNA Damage Repair and Serves as a Prognostic Biomarker in Lung Adenocarcinoma. Dose-Response, 24(3). https://doi.org/10.1177/15593258261473591

Vancouver

Zou L, Ren B, Wan Y, Wang X, Shen R, Zhu W, et al. Peptidylprolyl Isomerase a Regulates DNA Damage Repair and Serves as a Prognostic Biomarker in Lung Adenocarcinoma. Dose-Response. 2026;24(3). doi:10.1177/15593258261473591

BibTeX
@article{Zou2026,
  author = {Zou, Li and Ren, Bixin and Wan, Ying and Wang, Xin and Shen, Ruichi and Zhu, Wenlang and Jin, Limin and Peng, Qiliang and Tian, Ye},
  title = {Peptidylprolyl Isomerase a Regulates DNA Damage Repair and Serves as a Prognostic Biomarker in Lung Adenocarcinoma},
  journal = {Dose-Response},
  year = {2026},
  volume = {24},
  number = {3},
  doi = {10.1177/15593258261473591}
}
Kostenlos starten →